(Q36856681)

16 August 2017

1 reference

title

Consortium approach to identifying genes for Barrett's esophagus and esophageal adenocarcinoma (English)

1 reference

16 August 2017

0 references

Heather M Ochs-Balcom

1

object named as

Heather M Ochs-Balcom

1 reference

16 August 2017

7

Charis Eng

1 reference

16 August 2017

Gary Falk

2

1 reference

16 August 2017

William M Grady

3

1 reference

16 August 2017

Margaret Kinnard

4

1 reference

16 August 2017

Joseph Willis

5

1 reference

16 August 2017

Robert Elston

6

1 reference

16 August 2017

Amitabh Chak

8

1 reference

16 August 2017

language of work or name

1 reference

25 May 2007

1 reference

16 August 2017

published in

Translational Research

1 reference

16 August 2017

volume

150

1 reference

16 August 2017

issue

1

1 reference

16 August 2017

page(s)

3-17

1 reference

Chronic peptic ulcer of the oesophagus and 'oesophagitis'.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

The role of pepsin in acid injury to esophageal epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Are we underestimating acid reflux?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Bile salts induce or blunt cell proliferation in Barrett's esophagus in an acid-dependent fashion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Is Barrett's metaplasia the source of adenocarcinomas of the cardia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Intestinal metaplasia is the probable common precursor of adenocarcinoma in barrett esophagus and adenocarcinoma of the gastric cardia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Screening for Barrett's esophagus in colonoscopy patients with and without heartburn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Reflux, Barrett's oesophagus and adenocarcinoma: burning questions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Prevalence of Barrett's esophagus in the general population: an endoscopic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Prevalence of Barrett's esophagus in asymptomatic individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Prevalence of precancerous and other metaplasia in the distal oesophagus and gastro-oesophageal junction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Barrett's esophagus is common in older men and women undergoing screening colonoscopy regardless of reflux symptoms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Surveillance and survival in Barrett's adenocarcinomas: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

7 January 2021

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Adenocarcinoma in Barrett's oesophagus: an overrated risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Risk of adenocarcinoma in Barrett's oesophagus: population based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Familial gastroesophageal reflux and development of Barrett's esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Barrett esophagus in sexagenarian identical twins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

A family history of Barrett's oesophagus: Another risk factor?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Identification of Barrett's esophagus in relatives by endoscopic screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

A new questionnaire for gastroesophageal reflux disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Demographic and phenotypic features of 70 families segregating Barrett's oesophagus and oesophageal adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Familiality in Barrett's esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Gastroesophageal reflux symptoms in patients with adenocarcinoma of the esophagus or cardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Inhibition of cyclooxygenase: a novel approach to cancer prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

p53 and p21(WAF1/CIP1/SDI1) gene products in Barrett esophagus and adenocarcinoma of the esophagus and esophagogastric junction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Expression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) and p53 tumor suppressor in dysplastic progression and adenocarcinoma in Barrett esophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Regulation of Cdx2 expression by promoter methylation, and effects of Cdx2 transfection on morphology and gene expression of human esophageal epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Chronic acid exposure leads to activation of the cdx2 intestinal homeobox gene in a long-term culture of mouse esophageal keratinocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

Barrett's esophagus: development of dysplasia and adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2007.02.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRSL.2007.02.005

1 reference

16 August 2017

1 reference